ArticleParasite (Paris, France)2019
Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra
Article in Parasite (Paris, France), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Systematic review on infection and disease caused by Thelazia callipaeda in Europe: 2001-2020.Parasite (Paris, France) · 2020Pooled it
- First molecularly confirmed case of canine thelaziosis due to Thelazia callipaeda infection in Estonia.Acta veterinaria Scandinavica · 2026Article
- From Asia to Europe: epidemiology, genetic diversity, and One Health implications of Thelazia callipaeda.Parasite (Paris, France) · 2026Review
- Characteristics of canine thelaziasis in the Republic of Korea: a retrospective study (2022-2024).Journal of veterinary science · 2025Article
- Efficacy of a combination of esafoxolaner, eprinomectin and praziquantel (NexGardParasite (Paris, France) · 2024Article
- Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica TrioParasites & vectors · 2022Article
- Laboratory Culture and Life Cycle ofPathogens (Basel, Switzerland) · 2022Article
- Feline thelaziosis (Journal of feline medicine and surgery · 2021Article
- Efficacy of fipronil/(S)-methoprene/eprinomectin/praziquantel (BroadlineParasites & vectors · 2021Article
- Ophthalmic Thelazia callipaeda infections: first feline and new canine imported cases in Germany.Parasitology research · 2020Article
- The first autochthonous case of feline ocular thelaziosis in Austria.Parasitology research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past decade, canine thelaziosis due to Thelazia callipaeda has been diagnosed in an increasing number of European countries, with endemic areas being identified. A multi-center field trial was conducted in endemic areas in France and Spain to evaluate the efficacy of monthly administrations of the oral milbemycin oxime/afoxolaner combination (NexGard Spectra
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.